Literature DB >> 14962120

Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis.

Michael Detmar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14962120     DOI： 10.1046/j.0022-202X.2003.22140.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  15 in total

1.  Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.

Authors:  Abdel-Raheim M A Meki; Hani Al-Shobaili
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

2.  Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes.

Authors:  Traci A Wilgus; Annette M Matthies; Katherine A Radek; Julia V Dovi; Aime L Burns; Ravi Shankar; Luisa A DiPietro
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes.

Authors:  Xiao-Yong Man; Wei Li; Jia-Qi Chen; Jiong Zhou; Lilla Landeck; Kai-Hong Zhang; Zhen Mu; Chun-Ming Li; Sui-Qing Cai; Min Zheng
Journal:  Cell Mol Life Sci       Date:  2013-01-19       Impact factor: 9.261

4.  Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

Authors:  Peter M Elias; Jack Arbiser; Barbara E Brown; Heidemarie Rossiter; Mao-Qiang Man; Francesca Cerimele; Debra Crumrine; Roshan Gunathilake; Eung Ho Choi; Yoshikazu Uchida; Erwin Tschachler; Kenneth R Feingold
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

5.  IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Authors:  Theoharis C Theoharides; Bodi Zhang; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; Shahrzad Asadi; Nikolaos Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

6.  Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.

Authors:  Shahrzad Asadi; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Alexandra Miniati; Nikolaos Sismanopoulos; Magdalini Vasiadi; Bodi Zhang; Dimitrios Kalogeromitros; Theoharis C Theoharides
Journal:  J Invest Dermatol       Date:  2011-11-17       Impact factor: 8.551

Review 7.  Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.

Authors:  Marta E Alarcón-Riquelme
Journal:  Arthritis Res Ther       Date:  2004-06-21       Impact factor: 5.156

8.  Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF.

Authors:  Xiao-Yong Man; Xiao-Hong Yang; Sui-Qing Cai; Zhang-Yu Bu; Min Zheng
Journal:  J Cell Mol Med       Date:  2008-04       Impact factor: 5.310

9.  Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin.

Authors:  Zuyi Weng; Arti B Patel; Magdalini Vasiadi; Anastasia Therianou; Theoharis C Theoharides
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene.

Authors:  Tuba Bozduman; Sibel Ersoy Evans; Sevilay Karahan; Yildiz Hayran; Filiz Akbiyik; Incilay Lay
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.